HZB and ANSTO have extended their Memorandum of Understanding

<span class="Beschriftung1"><span>ANSTO: Adi Paterson and Simone Richter, HZB: Prof Anke Kaysser-Pyzalla and Thomas Frederking. </span></span>

ANSTO: Adi Paterson and Simone Richter, HZB: Prof Anke Kaysser-Pyzalla and Thomas Frederking. © ANSTO

Advancing energy materials research together

The heads of the HZB and the Australian Nuclear Science and Technology Organisation (ANSTO) recently have considerably extended the Memorandum of Understanding existing between the two institutions since 2015. They intend to further enhance their cooperation particularly in the area of energy materials research.

The memorandum comprises agreements on the exchange of personnel, advanced training, and reciprocal access to instruments located at the large-scale facilities of ANSTO and the HZB. The Australian Nuclear Science and Technology Organisation (ANSTO) research hub is located near Sydney, operating a synchrotron source as well as other infrastructures including the OPAL research reactor and Australian Centre for Neutron Scattering. ANSTO will be taking over the BioRef-Reflektometer for conducting research on soft matter and solid-state/liquid interfaces from BER II, the Berlin-based neutron source that will be shut down at the end of 2019. It will be available to the user community beginning 2018 under the name “Spatz” (German for “sparrow”). ANSTO is also active in the field of accelerator research, one in which HZB has likewise attained an international reputation.

Moreover, HZB has enhanced its collaboration with other leading Australian institutions. In summer 2016, Monash University appointed three HZB scientists from the field of energy materials research as adjunct professors.

More Information on ANSTO: http://www.ansto.gov.au

arö

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.